124 related articles for article (PubMed ID: 37267864)
1. High expression of PKCλ and ALDH1A3 indicates a poor prognosis, and PKCλ is required for the asymmetric cell division of ALDH1A3-positive cancer stem cells in PDAC.
Kasai T; Tamori S; Takasaki Y; Matsuoka I; Ozaki A; Matsuda C; Harada Y; Sasaki K; Ohno S; Akimoto K
Biochem Biophys Res Commun; 2023 Aug; 669():85-94. PubMed ID: 37267864
[TBL] [Abstract][Full Text] [Related]
2. GLO 1 and PKCλ Regulate ALDH1-positive Breast Cancer Stem Cell Survival.
Motomura H; Tamori S; Yatani MA; Namiki A; Onaga C; Ozaki A; Takasawa R; Mano Y; Sato T; Hara Y; Sato K; Xiong Y; Harada Y; Hanawa T; Tanuma SI; Sasaki K; Ohno S; Akimoto K
Anticancer Res; 2021 Dec; 41(12):5959-5971. PubMed ID: 34848450
[TBL] [Abstract][Full Text] [Related]
3. High PKCλ expression is required for ALDH1-positive cancer stem cell function and indicates a poor clinical outcome in late-stage breast cancer patients.
Nozaki Y; Motomura H; Tamori S; Kimura Y; Onaga C; Kanai S; Ishihara Y; Ozaki A; Hara Y; Harada Y; Mano Y; Sato T; Sato K; Sasaki K; Ishiguro H; Ohno S; Akimoto K
PLoS One; 2020; 15(7):e0235747. PubMed ID: 32658903
[TBL] [Abstract][Full Text] [Related]
4. High Expression of
Motomura H; Nozaki Y; Onaga C; Ozaki A; Tamori S; Shiina TA; Kanai S; Ohira C; Hara Y; Harada Y; Takasawa R; Hanawa T; Tanuma SI; Mano Y; Sato T; Sato K; Akimoto K
Anticancer Res; 2020 Jan; 40(1):35-52. PubMed ID: 31892551
[TBL] [Abstract][Full Text] [Related]
5. Luminal B Breast Cancer Coexpressing
Ozaki A; Matsuda A; Maemura Y; Tada Y; Kasai T; Nagashima Y; Onaga C; Hara Y; Kitabatake K; Tsukimoto M; Tamori S; Sasaki K; Ohno S; Akimoto K
Anticancer Res; 2024 Jan; 44(1):37-47. PubMed ID: 38160009
[TBL] [Abstract][Full Text] [Related]
6. Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma.
Nimmakayala RK; Leon F; Rachagani S; Rauth S; Nallasamy P; Marimuthu S; Shailendra GK; Chhonker YS; Chugh S; Chirravuri R; Gupta R; Mallya K; Prajapati DR; Lele SM; C Caffrey T; L Grem J; Grandgenett PM; Hollingsworth MA; Murry DJ; Batra SK; Ponnusamy MP
Oncogene; 2021 Jan; 40(1):215-231. PubMed ID: 33110235
[TBL] [Abstract][Full Text] [Related]
7. Fetal bovine serum enlarges the size of human pancreatic cancer spheres accompanied by an increase in the expression of cancer stem cell markers.
Sasaki N; Toyoda M; Hasegawa F; Fujiwara M; Gomi F; Ishiwata T
Biochem Biophys Res Commun; 2019 Jun; 514(1):112-117. PubMed ID: 31027735
[TBL] [Abstract][Full Text] [Related]
8. Differentially Expressed microRNAs in MIA PaCa-2 and PANC-1 Pancreas Ductal Adenocarcinoma Cell Lines are Involved in Cancer Stem Cell Regulation.
Shen Y; Pu K; Zheng K; Ma X; Qin J; Jiang L; Li J
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31510100
[TBL] [Abstract][Full Text] [Related]
9. microRNA-21 Regulates Stemness in Pancreatic Ductal Adenocarcinoma Cells.
Mortoglou M; Miralles F; Arisan ED; Dart A; Jurcevic S; Lange S; Uysal-Onganer P
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163198
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic ductal adenocarcinoma cell lines display a plastic ability to bi‑directionally convert into cancer stem cells.
Dalla Pozza E; Dando I; Biondani G; Brandi J; Costanzo C; Zoratti E; Fassan M; Boschi F; Melisi D; Cecconi D; Scupoli MT; Scarpa A; Palmieri M
Int J Oncol; 2015 Mar; 46(3):1099-108. PubMed ID: 25502497
[TBL] [Abstract][Full Text] [Related]
11. RNA Polymerase II-Associated Factor 1 Regulates Stem Cell Features of Pancreatic Cancer Cells, Independently of the PAF1 Complex, via Interactions With PHF5A and DDX3.
Karmakar S; Rauth S; Nallasamy P; Perumal N; Nimmakayala RK; Leon F; Gupta R; Barkeer S; Venkata RC; Raman V; Rachagani S; Ponnusamy MP; Batra SK
Gastroenterology; 2020 Nov; 159(5):1898-1915.e6. PubMed ID: 32781084
[TBL] [Abstract][Full Text] [Related]
12. Gemcitabine treatment induces endoplasmic reticular (ER) stress and subsequently upregulates urokinase plasminogen activator (uPA) to block mitochondrial-dependent apoptosis in Panc-1 cancer stem-like cells (CSCs).
Wang L; Zhang Y; Wang W; Zhu Y; Chen Y; Tian B
PLoS One; 2017; 12(8):e0184110. PubMed ID: 28854261
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic cancer stem cells: features and detection methods.
Ishiwata T; Matsuda Y; Yoshimura H; Sasaki N; Ishiwata S; Ishikawa N; Takubo K; Arai T; Aida J
Pathol Oncol Res; 2018 Oct; 24(4):797-805. PubMed ID: 29948612
[TBL] [Abstract][Full Text] [Related]
14. FoxO1-negative cells are cancer stem-like cells in pancreatic ductal adenocarcinoma.
Song W; Li Q; Wang L; Huang W; Wang L
Sci Rep; 2015 Jun; 5():10081. PubMed ID: 26068418
[TBL] [Abstract][Full Text] [Related]
15. The extracellular matrix and focal adhesion kinase signaling regulate cancer stem cell function in pancreatic ductal adenocarcinoma.
Begum A; Ewachiw T; Jung C; Huang A; Norberg KJ; Marchionni L; McMillan R; Penchev V; Rajeshkumar NV; Maitra A; Wood L; Wang C; Wolfgang C; DeJesus-Acosta A; Laheru D; Shapiro IM; Padval M; Pachter JA; Weaver DT; Rasheed ZA; Matsui W
PLoS One; 2017; 12(7):e0180181. PubMed ID: 28692661
[TBL] [Abstract][Full Text] [Related]
16. ALDH1-high ovarian cancer stem-like cells can be isolated from serous and clear cell adenocarcinoma cells, and ALDH1 high expression is associated with poor prognosis.
Kuroda T; Hirohashi Y; Torigoe T; Yasuda K; Takahashi A; Asanuma H; Morita R; Mariya T; Asano T; Mizuuchi M; Saito T; Sato N
PLoS One; 2013; 8(6):e65158. PubMed ID: 23762304
[TBL] [Abstract][Full Text] [Related]
17. Ezrin Promotes Stem Cell Properties in Pancreatic Ductal Adenocarcinoma.
Penchev VR; Chang YT; Begum A; Ewachiw T; Gocke C; Li J; McMillan RH; Wang Q; Anders R; Marchionni L; Maitra A; Uren A; Rasheed Z; Matsui W
Mol Cancer Res; 2019 Apr; 17(4):929-936. PubMed ID: 30655325
[TBL] [Abstract][Full Text] [Related]
18. Minnelide effectively eliminates CD133(+) side population in pancreatic cancer.
Nomura A; McGinn O; Dudeja V; Sangwan V; Saluja AK; Banerjee S
Mol Cancer; 2015 Nov; 14():200. PubMed ID: 26597727
[TBL] [Abstract][Full Text] [Related]
19. Multifunctional roles of urokinase plasminogen activator (uPA) in cancer stemness and chemoresistance of pancreatic cancer.
Asuthkar S; Stepanova V; Lebedeva T; Holterman AL; Estes N; Cines DB; Rao JS; Gondi CS
Mol Biol Cell; 2013 Sep; 24(17):2620-32. PubMed ID: 23864708
[TBL] [Abstract][Full Text] [Related]
20. PPAR/PDK4 pathway is involved in the anticancer effects of cGMP in pancreatic cancer.
Yamashita M; Kumazoe M; Onda H; Hiroi S; Shimada Y; Fujimura Y; Tachibana H
Biochem Biophys Res Commun; 2023 Sep; 672():154-160. PubMed ID: 37354608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]